Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Maravai Lifesciences Holdings Inc Cl A (NQ: MRVI )

7.735 +0.015 (+0.19%)
Streaming Delayed Price Updated: 11:40 AM EDT, Apr 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Maravai Lifesciences Holdings Inc Cl A

< Previous 1 2 Next >
TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production
From TriLink BioTechnologies
Via Business Wire
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Dyadic International Inc. (NASDAQ: DYAI) Funding to Propel Near-Term Revenue Growth Initiatives Highlights in Zacks Small-Cap Research Report
Via AB Newswire
Topics Regulatory Compliance
Exposures Legal Regulatory
Maravai LifeSciences Announces March 2024 Investor Conference Schedule
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Market Momentum: NASDAQ SmallCaps Sparking Waves in March 2024: CELZ, DYAI, GROM, VTAK, BREA
Via AB Newswire
Exposures Product Safety
Recent Market Movers: Healthcare Companies Making Headlines: DYAI, RIGL, ARDX, VERO, MEDS
Via AB Newswire
Healthcare Undervalued Opportunities Poised for Growth: DYAI, INBS, VTAK, RSCI, VERO, MRVI
Via AB Newswire
Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial Results
Continued Focus on Expanding Product Portfolio, Market Leadership and Innovation 
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
TriLink BioTechnologies® Solidifies IP Position with Awarded Patents for CleanCap® Capping Technology in China and Canada
From TriLink BioTechnologies
Via Business Wire
Nasdaq Stocks Are Taking Center Stage This Week! DYAI, MRVI, SPWR, VTAK, KAVL, INBS
Via AB Newswire
Biopharmaceutical Advancements: Dyadic (Nasdaq: DYAI) Raises Industry Standards with Maravai LifeSciences’ (Nasdaq: MRVI) Cygnus Technologies
Via AB Newswire
Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing
From Dyadic International, Inc.
Via GlobeNewswire
Maravai LifeSciences To Host Earnings Conference Call on Thursday, February 22, 2024
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences Announces November 2023 Investor Conference Schedule
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences Reports Third Quarter 2023 Financial Results
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
TriLink BioTechnologies® Expands Capabilities with Launch of ‘Analytical Sciences Center of Excellence’
From TriLink BioTechnologies
Via Business Wire
Maravai LifeSciences To Host Earnings Conference Call on Tuesday, November 7, 2023
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences Hosts 2023 Investor R&D Day
Highlights include the company’s strong foundation for growth, focus on innovation and attractive long-term outlook 
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences Chief Innovation Officer Kate Broderick Named to 2023 PharmaVoice 100
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences to Host 2023 Investor R&D Day
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Cygnus Technologies Receives 2023 R&D 100 Award for MockV® RVLP Kit
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences Announces August 2023 Investor Conference Schedule
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences Reports Second Quarter 2023 Financial Results
Continued Focus on Expanding Product Portfolio, Market Leadership and Scientific Innovation 
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences Announces Completion of Planned CEO Leadership Transition
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences To Host Earnings Conference Call on Monday, August 7, 2023
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences Announces Appointment of New Director to the Board
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Congressman Scott Peters Tours Maravai’s RNA manufacturing facility
Congressman Peters (D-CA-50) tours Wateridge manufacturing site in San Diego and celebrates Maravai’s impact in COVID vaccine production 
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
TriLink BioTechnologies® Announces Manufacturing Capabilities Expansion as mRNA Manufacturing Facility Nears Completion
From TriLink BioTechnologies
Via Business Wire
TriLink BioTechnologies Introduces Latest mRNA Capping Technology: CleanCap® M6 analog
Newest cap analog product improves mRNA potency with greater protein expression, offers time and cost savings, and streamlines manufacturing to drive critical therapeutic and vaccine development 
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences Reports First Quarter 2023 Financial Results
Continued Focus on Expanding Product Portfolio, Market Leadership and Scientific Innovation 
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.